Sagimet Biosciences Inc (SGMT) Implied Volatility Current

Tracking SGMT implied volatility helps you identify when options premiums on Sagimet Biosciences Inc are historically cheap or expensive, and where the best trades are hiding. Sagimet Biosciences Inc implied volatility reflects the market's expectation of future price movement: when SGMT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Sagimet Biosciences Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For SGMT, tracking metrics like SGMT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on SGMT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where SGMT implied volatility sits today versus where it has been. Our scanner ranks Sagimet Biosciences Inc implied volatility against its historical range, surfaces extremes in SGMT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Sagimet Biosciences Inc IV is rich or cheap — measure it, then act on it.